Thank you for visiting the Astellas Pharma Inc. Website.
You will enter external sites beyond here.
(This link opens in a new window)
Executive Committee（as of October 2019）
The Executive Committee discusses important matters of management across Astellas. It is chaired by the Representative Director, President and CEO, and comprises top management as standing members. Extended members include the officers responsible for research, development and pharmaceutical technology capabilities together with the officers responsible for each region, and these members participate in any necessary discussions at the request of the chairman.
Standing Members
| Representative Director, President and CEO |
Kenji Yasukawa, Ph.D. |
| Representative Director, Corporate Executive Vice President, Chief Strategy Officer (CStO) and Chief Financial Officer (CFO) |
Naoki Okamura |
| Chief Administrative Officer and Chief Ethics & Compliance Officer |
Fumiaki Sakurai |
| General Counsel | Linda Friedman |
| Chief Medical Officer | Bernhardt Zeiher, M.D. |
| Chief Commercial Officer | Yukio Matsui |
Extended Members
| President, Drug Discovery Research | Akihiko Iwai |
| President, Pharmaceutical Technology | Hideki Shima |
| President, Development | Steven Benner |
| President, Established Markets Commercial | Dirk Kosche |
| President, Greater China Commercial | Hiroshi Hamaguchi |
| President, International Commercial | Claus Zieler |
| President, Japan Commercial | Nobuaki Tanaka |
| President, US Commercial | Percival Barretto-Ko |
Group Management Structure (As of April 1, 2019)
